The FDA will not enforce FDCA provisions that typically prohibit compounding of essentially a copy of an approved drug until February 18, 2025, for 503A pharmacies and March 19, 2025, for 503B outsourcing facilities
Table of Contents If youve ever done everything right and still felt stuck, youre not imagining it
A study that followed 10,00 patients found that GLP-1 users were far less likely to progress to a worse stage of cancer across four types of solid tumors
Novo Nordisk, the manufacturer of Wegovy, sponsors NovoCare, a website with resources that help people check insurance coverage, manage the cost of medication, explore savings and assistance options, and more
LAURA: Ozempic also has a text program with reminders and other tips, and there are great options for savings and support on their website